Resynchronization slows heart failure progressionBut study results leave cardiologists wrestling with questions of cost and patient selection Doubling clopidogrel dose makes for safer angioplastyDecrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study New antiplatelet agent reduces cardiovascular events Ezetimibe-atorvastatin combo proves effective Pregnancy feasible for heart recipients But better counselling needed on drug risks and long-term maternal survival Antiplatelet agents unaffected by proton pump inhibitors Clinical Feature: Dysplipidemia A look at current issues and what’s new in management. What are the causes and treatments for anemia of chronic disease? What are the causes and drug treatments for “anemia of chronic disease” and anemia resulting from chronic renal failure? Getting to the heart of it Community management of the post-myocardial infarction patient. The gender divide: heart failure differs in women Physicians should be aware of variance in symptoms, age at onset and comorbidities in female patients First Previous 88 89 90 91 92 Next Last
